In T1DM with an SNP (rs12150220) in NLRP1, the levels of IL‐17 and memory Th17 cells were decreased in peripheral blood mononuclear cells, proving that NLRP1 is a potential therapy target.120. This evidence concerns the gene NLRP1 and type 1 diabetes mellitus.